New Scientist Study

Doctoral Candidates - Berlin

Thu, 08 Jul 2010 14:56:18 +0100

Doctoral Candidates - Berlin

STUDYing in Berlin

INFECTIOUS DISEASES AND IMMUNE REACTIONS

12 Extraordinary Projects Look for Doctoral Candidates to begin April 2011 (or earlier)

Deadline for Application - September 15, 2010

The ZIBI Graduate School Berlin is an international doctoral program. Research projects aim to elucidate genetic, biochemical and organismal basis of infections andi mmune reactions.

They are in the areas ofHost-pathogen interactionEpigenetic changes in infectionStructure-function analyses of pathogenicity componentsDifferentiation of immune cellsHost-pathogen co-evolutionAntiviral andanti microbial strategies andv accine development

We offer outstanding training and support in an excellent scientific network. Faculty members are affiliatedto well-known institutes such as the Max Planck Institute for Infection Biology, the German Rheumatism Research Center, the Robert Koch Institute, the Institute for Zoo andW ildlife Research as well as to institutes of the Humboldt University to Berlin, the Free University of Berlin and the Charité - University Medicine Berlin.

Our mission is to develop students into creative, responsible and self-confident young researchers. Therefore, we are looking for highly motivateds tudents of all nationalities who are strongly committed to research.

For further information and online application, please visit our website.

Contact: ZIBI Graduate School, c/o Dr. Susann Beetz,

Max Planck Institute for Infection Biology, Campus CharitéMitte, Charitéplatz 1, 10117 Berlin, Germany

Phone: +49 (0) 30 28460160, email: info@zibi-graduateschool-berlin.de

The ZIBI Graduate School is the roof of: International Max Planck Research School for Infectious Diseases andImmunol ogy (IMPRS-IDI) fundedb y the Max Planck Society (MPG)

Research Training Group "Genetic andImmunol ogic Determinants of Pathogen- Host-Interactions" (GRK1121) funded by the German Research Foundation (DFG)

NFECTIOUS DISEASES AND IMMUNE REACTIONS - Berlin

Mon, 05 Jul 2010 13:37:53 +0100

STUDYing in Berlin
NFECTIOUS DISEASES AND IMMUNE REACTIONS

12 Extraordinary Projects Look for Doctoral Candidates to begin April 2011 (or earlier)

Deadline for Application - September 15, 2010

The ZIBI Graduate School Berlin is an international doctoral program. Research projects aim to elucidate genetic, biochemical and organismal basis of infections and immune reactions.

They are in the areas of
- Host-pathogen interaction
- Epigenetic changes in infection
- Structure-function analyses of pathogenicity components
- Differentiation of immune cells
- Host-pathogen co-evolution
- Antiviral and antimicrobial strategies and vaccine development

We offer outstanding training and support in an excellent scientific network. Faculty members are affiliated to well-known institutes such as the Max Planck Institute for Infection Biology, the German Rheumatism Research Center, the Robert Koch Institute, the Institute for Zoo and Wildlife Research as well as to institutes of the Humboldt University to Berlin, the Free University of Berlin and the Charité - University Medicine Berlin.

Our mission is to develop students into creative, responsible and self-confident young researchers. Therefore, we are looking for highly motivated students of all nationalities who are strongly committed to research.

For further information and online application, please visit our website via the 'Apply Now' button.

The ZIBI Graduate School is the roof of:

International Max Planck Research School for Infectious Diseases and Immunology (IMPRS-IDI)
funded by the Max Planck Society (MPG) Research Training Group “Genetic and Immunologic Determinants of Pathogen- Host-Interactions” (GRK1121)
funded by the German Research Foundation (DFG)

Doctoral Positions in Pulmonary Research - Germany

Fri, 04 Jun 2010 08:02:02 +0100

Doctoral Positions in Pulmonary Research - Germany

Doctoral Positions in Pulmonary Research in Germany

The International Graduate Program "Molecular Biology and Medicine of the Lung" (MBML) is the leading educational platform of the University of Giessen Lung Center at the Justus Liebig University in Giessen, Germany. We are now seeking highly qualified and motivated individuals for full-time doctoral studies in several areas of lung physiology and pathology. Research topics include genetic programmes that drive early and late lung development, the genetic and physiological basis of pulmonary diseases, including pulmonary hypertension; acute lung injury and pulmonary oedema; lung fibrosis, lung cancer, chronic obstructive pulmonary disease, including emphysema; cystic fibrosis; lung transplantation; fungal, viral and bacterial infections of the lung; and bronchopulmonary dysplasia. The research is undertaken in a dynamic and exciting research environment. The University of Giessen Lung Center is one of the world's leading pulmonary centres, and is recognised for excellence both in basic scientific research and in the clinical management of patients with lung disease.

Applications are welcomed from candidates trained in any biological discipline, and well as applicants with a primary degree in human or veterinary medicine. Students will receive a monthly stipend, and depending on their qualifications and the projects selected, may be eligible to register for one of the four doctoral degrees offered, including the PhD, the Dr rer. Nat., the Dr. biol. Hum. and the Dr. med. Candidates must be in possession of a Master's degree in the life sciences, or a primary degree in human or veterinary medicine, by 1st October 2010. Candidates will be expected to attend an interview in Giessen prior to formal acceptance (all expenses will be covered by the University of Giessen), and are free to start their laboratory research anytime after that interview. The formal coursework starts on 6th October 2010. Please consult the MBML Programme webpage www.uniklinikumgiessen.de/mbml for information about the Programme.

Applications, consisting of (i) a letter stating your intention to apply, (ii) a current curriculum vitae, (iii) a list of three potential referees, and (iv) your academic transcripts, compiled into a single PDF file of maximum size 1 MB, should be submitted via the ‘Apply Now’ button. Please direct any enquiries to Dr Rory E. Morty (rory.morty@innere.med.uni-giessen.de).

PhD positions - Germany

Fri, 04 Jun 2010 08:01:57 +0100

PhD positions - Germany

Earn your PhD in an Interdisciplinary Environment

International Research at the MPGC

The Max Planck Graduate Center with the Johannes Gutenberg-Universität Mainz is a newly established interdisciplinary graduate school in sciences. It benefits from the excellence of two Max Planck Institutes and one of the largest universities in Germany. Research fields build bridges between the traditional disciplines of biology, chemistry, mathematics, physics and medicine. The location is Mainz, an attractive mid-size student city in the Middle Rhine Valley in the Western part of Germany.

The MPGC offers about 20 PhD positions in 2010.

Applications of excellent candidates with a Master of Science are welcome at any time. Please visit our website and contact us!

Max Planck Graduate Center with the Johannes Gutenberg-Universität Mainz, Staudinger Weg 9 (Bdg 2431), 55128 Mainz / Germany

E-mail: info@mpgc-mainz.de

Postdoctoral and Predoctoral research positions - Frankfurt

Thu, 29 Apr 2010 12:06:35 +0100

Postdoctoral and Predoctoral research positions - Frankfurt

Postdoctoral and Predoctoral research positions are open in the cryoelectron tomography group at the Goethe University Frankfurt. The research is funded by the European Research Council (ERC) and the European Commission seventh framework programme (EU FP7).

The group of Dr. Frangakis (www.biophysik.org/frangakis/) at the Frankfurt Institute for Molecular Life Science is an interdisciplinary team of biologists, physicists, and computational scientists. We use cryoelectron tomography to visualize biological systems, and provide new insights into the three-dimensional ultrastructure of eukaryotic cells. Our images can achieve molecular resolution in vivo, which allows us to generate a quasi-atomic atlas of supramolecular structures.

The lab is equipped with latest technology electron (FEI Titan Krios) and light microscopes as well as state-of-the-art accompanying equipment. Additionally, a supercomputer (with 5000 CPU and 1000 GPU nodes) covers our image processing requirements.

Investigation of the chromatin structure

Aim of the project is to study the structure of the chromatin fiber and elucidate its role in fundamental biological processes such as transcription or silencing. Despite its importance and the effort over three decades, the structure of the 30nm chromatin fiber remains controversial. Towards this goal a combination of in vitro and in vivo samples will be used.

Investigation of adhesion junctions in mouse models

Aim of the project is to structurally characterize adhesion junctions in toto by cryo-electron tomography of vitreous sections. Adhesion junctions are clusters of membrane-associated proteins that are involved in intercellular contacts. We aim to reveal the molecular organization of several adhesion junctions, and their implications in cellular proliferation and disease.

The successful candidates should be highly motivated and have a profound knowledge in Cell Biology, Biochemistry, Biophysics or related fields. First experience in electron microscopy would be an advantage. The projects are funded by the Marie Curie ITN program Nucleosome4D and the ERC. Applicants must be nationals of an EU Member or Associated State, or have resided in the EU for at least five years immediately prior to their selection.

Interested candidates should send an application including a cover letter stating areas of expertise and interests, a CV, publication list and names and contact information for 3 references to Dr. Achilleas Frangakis (email via the ‘Apply Now’ button).

22 Ph.D. student positions - Germany

Fri, 26 Mar 2010 11:25:18 +0100

The prospective Bernstein-Center for Computational Neuroscience (BCCN) Heidelberg/ Mannheim, Germany, invites applications for

•22 Ph.D. student positions

Positions will start in May 2010 or later (provided funding is granted), and are to be filled within all areas of neuroscience, including computational, mathematical, cognitive, systems, behavioral, and molecular neuroscience, neuroimaging, neurogenetics, neuropsychology, neuropharmacology, and in-vitro/ in-vivo electrophysiology.

The BCCNs are a German governmental initiative in Computational Neuroscience (www.nncn.de) which aims to foster the tight integration of theoretical and experimental neuroscience. The BCCN Heidelberg/ Mannheim is devoted to the topic 'From Genes to Behavior’ and investigates the links between biophysical properties of neurons and synapses controlled by single genes, their impact on neural network dynamics and computation, and the implications in turn for normal and aberrant cognitive processing. For more information on participating groups see www.izn.uni-heidelberg.de/CNS.

A graduate school providing teaching and training in computational and experimental neuroscience methods will be established as part of the BCCN.

The Heidelberg University and the Central Institute of Mental Health (CIMH) Mannheim provide an internationally outstanding environment for neuroscience research. Heidelberg University was ranked as Germany’s top university in 2008 by Times Higher Education, and the CIMH is one of Europe's premier research institutions dedicated to mental health.

The Heidelberg University and the CIMH are committed to strengthen the proportion of women in research and teaching and strongly encourage applications of qualified female scientists. Handicapped applicants with equal qualification will be given preferential consideration.

Full applications including CV, copies of certificates, two references and brief description of reasons for application should be sent electronically to us by clicking 'APPLY NOW'.

International PhD Program in Life Sciences Münster, Germany

Thu, 25 Feb 2010 10:14:45 +0100

International PhD Program in Life Sciences
Münster, Germany

16 PhD Fellowships
starting October 2010

Research areas:
Cell and Molecular Biology
Stem Cell Biology
Developmental Biology
Neurobiology
Vascular Biology
Immunology
Microbiology
and more

Applications for the 3-year PhD program can be submitted from March 7 to May 20, 2010. Information about the program and its research projects as well as our online application system can be found at our website by clicking 'APPLY NOW'

The program offers cutting edge biomedical science with a strong emphasis on imaging
as well as excellent scientific and transferable skills training. The program language is English. There are no tuition fees.
CEDAD and IMPRS-MBM are jointly run by the University of Münster and the Max
Planck Institute for Molecular Biomedicine.
We invite applications from highly qualified and motivated students of any nationality.
Successful candidates will receive a competitive tax-free fellowship as well as support with visas, administrative matters, accomodation etc.

We are looking forward to your application for a PhD fellowship in Münster, "the world’s
most liveable city" (LivCom Award 2004).
Contact: Dr. Martin K. Wild, CEDAD / IMPRS-MBM, Schlossplatz 5, 48149 Münster,
Germany, cedad@uni-muenster.de

13 PhD Students / 13 Early Stage Researchers (ESR) - Throughout Europe

Mon, 01 Feb 2010 15:29:55 +0100

FP7 Marie Curie Initial Training Network (ITN)

FightingDrugFailure (Grant Agreement Number 238132)

Marie Curie Research Training Networks, an initiative of the Commission of the European Communities, provide training and research experiences for researchers at the beginning of their careers by giving them the opportunity to spend up to three years in another country as part of an international, high-quality research project. These training networks contribute to knowledge transfer through the promotion of multidisciplinary research and the interaction of researchers on all levels working within the project. FightingDrugFailure an ITN coordinated out of the Dr. Margarete Fischer-Bosch Institute of Clinical Pharmacology (IKP), and affiliate of the University of Tübingen, in Stuttgart, Germany, will focus on Pharmacogenomics with a goal of awarding 13 PhDs from Partner Sites in the area of Pharmacogenomics.

Pharmacogenetics is the scientific discipline that relates inter-individual variation in drug response and efficacy to genetic variation. While there have been major advances in basic genomic knowledge and genotyping technologies, translation into practice has been slow. It is essential we quicken the pace of translational research in pharmacogenomics – at present, we are only just beginning to be able to define which patients are going to respond to drugs, and which patients are going to develop adverse drug reactions.

Priorities and Standards in Pharmacogenomic Standards:

Opportunities for a Safer and More Efficient Pharmacotherapy

In this ITN, our concerted action across the EU, associated countries and an international cooperation partner country in collaboration with US researchers, will train young investigators and clinicians in the principles and scientific basis of Pharmacogenomics in order to establish, evaluate and retrieve relevant genetic information from patients and relate it to clinical outcomes of drug therapy. This will be achieved through sharing patient materials, performing pooled analyses, transferring knowledge and skills across laboratories and utilizing access to high-throughput technology platforms among 5 academic institutions and 4 industry partners. This will enhance translational research, promote uniform drug treatment standards throughout Europe and, ultimately, the world, and improve the competitiveness of the EU in this emerging and exciting new field.

We are currently seeking applications for

13 PhD Students / 13 Early Stage Researchers (ESR)

looking to complete a PhD Degree in Pharmacogenomics. This 3-year mobility program will provide eligible international students with in-depth-training in a core scientific area at a host institution as well as international experiences at both academic and industry partners. Short-term visits to partner facilities will provide students with network-wide training including interdisciplinary and intersectional transfer of knowledge and new techniques.

Early Stage Researchers (ESR) - students with completed academic degrees who are now eligible to embark on a doctorate and are in the first four years of their research careers

We offer

A PhD Program based on an international, cutting-edge Pharmacogenomic Curriculum (1st in Europe)
Individualized research and training plans encompassing both academic and industry settings tailored to each specific ESR’s educational needs
Working contracts with benefits adjusted to living conditions according to EU guidelines
International placements with relocation assistance
2 Flexible start dates – spring 2010, fall 2010
Complementary Skills Training including:
presentation skills, writing workshops, manuscript preparation, grant writing, scientific and administrative project management skills, laboratory management skills, networking skills, handling of research ethics, governance and property rights issues, computational skills
Career development counseling throughout the entire PhD program
Career exploratory allowance upon completion of the PhD program

Successful applicants

Possess an internationally recognized life science degree (i.e. Chemistry, Biology, Medicine, Mathematics, Pharmacology, etc.)
Must be eligible to pursue a PhD in Pharmacogenomics
Have less than four years research experience within their research careers
Desire to train within a mobility program throughout Europe, associated countries and an international cooperation partner country and are willing to relocate to the country where their host institution is located for the duration of the PhD Program
Are interested in working towards developing and strengthening international and interdisciplinary research collaborations
Are highly motivated and able to work both independently and as part of an interdisciplinary international team
Possess proficiency in the English language

Qualified applicants should direct a Curriculum Vitae with Cover Letter, Two Letters of Recommendation with contact email addresses and a List of Further Qualifications preferably via email to either the ITN Project Coordinator or one of the partner sites.

Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology
ITN Project Coordinator Prof. Hiltrud Brauch
Auerbach Str. 112
70367 Stuttgart
Germany

itn(AT)ikp-stuttgart.de

Cover Letters should indicate the applicant’s project or location of interest. Detailed descriptions of participating Partner Sites as well as Projects offered at each site can be found on our website www.fightingdrugfailure.net. All applications must be received by Feb. 28, 2010.